May 7, 2018 / 12:43 PM / 17 days ago

BRIEF-Stellar Biotechnologies Reports Q2 Loss Per Share Of $0.90

May 7 (Reuters) - Stellar Biotechnologies Inc:

* STELLAR BIOTECHNOLOGIES REPORTS SECOND QUARTER FINANCIAL RESULTS

* Q2 LOSS PER SHARE $0.90

* STELLAR BIOTECHNOLOGIES - AT MARCH 31, 2018, CO HAD WORKING CAPITAL OF $3.7 MILLION; CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS TOTALED $3.8 MILLION

* QTRLY TOTAL REVENUES WERE RELATIVELY UNCHANGED AT $0.06 MILLION COMPARED TO THE SAME PERIOD LAST YEAR Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below